[Gout and other crystal-induced arthritides].
Medizinische Klinik 3, Universitätsklinikum Erlangen, Universität Erlangen-Nürnberg, Ulmenweg 18, Erlangen. bernhard.manger@uk-erlangen.de
B
B
Manger
D015502:Absorptiometry, Photon; D000368:Aged; D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D015210:Arthritis, Gouty / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D002805:Chondrocalcinosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D003430:Cross-Sectional Studies; D004800:Enzymes, Immobilized; D019317:Evidence-Based Medicine; D000069465:Febuxostat; D005260:Female; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D013844:Thiazoles / Q000627:therapeutic use; D014463:Ultrasonography; D014503:Urate Oxidase / Q000009:adverse effects / Q000627:therapeutic use
D004800:Enzymes, Immobilized; D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D011092:Polyethylene Glycols; D000493:Allopurinol; D014503:Urate Oxidase; C031545:Pegloticase